Healthcare
RenovaCare, Inc.(RCAR)
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- โ
- Revenue Growth
- 0.0%
- EPS Growth
- +53.5%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RenovaCare, Inc. (RCAR) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +53.5%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +53.5%, free cash flow +4.2% with operating margin 0.0% and ROIC -224.7%. Stock Foundry combines RCAR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2022 was reported on Nov 18, 2022, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +53.5%, while operating margin sits near 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2022 Nov 18, 2022 | โ | +0.0% | +0.0% | +0.0% |
2022 Aug 12, 2022 | โ | +0.0% | +0.0% | +0.0% |
2022 May 12, 2022 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RCAR
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RCAR Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RCAR and SPY.
Company Overview
RenovaCare, Inc.
Other OTC
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.
- Leadership
- Harmel S. Rayat
- IPO Date
- May 30, 1996
- Employees
- 1
- Street Address
- 9375 East Shea Blvd
- Mailing
- Scottsdale, AZ, 85260
- Region
- Scottsdale, AZ, US
- Reporting Currency
- USD
- Investor Line
- 888 398 0202
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 0.5
- Price/Sales
- โ
- Price/Book
- 0.0
Growth
- Revenue
- 0.0%
- EPS
- +53.5%
- Free Cash Flow
- +4.2%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- -94.7%
- ROIC
- -224.7%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 2.59
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.